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Abstract 
Background: Screening for type 2 diabetes is recommended for women with previous gestational diabetes (GDM). 
However, the screening rates remain low. We aimed to evaluate the reminders and reminder systems for women with 
previous GDM and the health professionals in primary and secondary health care with screening rate among postpar-
tum women as primary outcome.
Methods: Observational and intervention studies were included and the PRISMA guidelines were followed for the 
literature extraction.
Results: Six studies were included: two long-term follow up studies and four early terms. Five studies focused on 
secondary care settings and one on primary care. Three studies focused on reminders to postpartum women only, 
two studies to both the women and health care professional, and one study on the health care provider only. Types 
of reminders varied from letters, emails, and personal telephone calls to the women to register-based reminders or 
letters to the health care professionals. Reminders were efficient but efficiency varied between studies. Two stud-
ies found that direct telephone calls strengthened the reminding of the women. The effect of reminding both the 
women and the health professional screening rates decreased compared to reminding either health professionals or 
reminding the women separately.
Conclusions: Reminders have a potential for early detection and prevention of type 2 diabetes in this high risk group 
of women; however, the kind of reminder and the frequency of reminders should be carefully considered accordingly 
to the target group.
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Background
Gestational diabetes mellitus (GDM) is an increas-
ing health concern in many middle-and high income 
countries and is mainly associated with the increas-
ing prevalence of overweight and obesity. Worldwide, it 
is estimated that 16  % of live births in 2013 were com-
plicated by hyperglycemia during pregnancy [1]. It is 
crucial for women with GDM to maintain a tight con-
trol of blood glucose level throughout the pregnancy to 
avoid complications such as macrosomia, preeclamp-
sia or perinatal mortality [1]. However, also after giving 
birth the blood glucose level has to be monitored. From 
a meta-analysis it was found that women with prior ges-
tational diabetes had a seven-fold risk of developing type 
2 diabetes within 5 years after giving birth [2]. The pro-
gression from being at risk for type 2 diabetes (T2D) to 
overt diabetes can be prevented or postponed by life style 
changes that include a healthy diet and regular physical 
activity, accompanied by weight loss if the women are 
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overweight or obese [3]. To prevent type 2 diabetes and 
to ensure early detection of a potential developing glu-
cose metabolism dysfunction, recurrent screening of the 
women should accompany the life style changes initiated 
to prevent hyper-glycemia during the GDM complicated 
pregnancy. The American Diabetes Association and 
other health authorities recommend the first postpartum 
screening for type 2 diabetes between 6 and 12  weeks 
after delivery followed by screening every 3 years [4, 5]. 
A questionnaire-based survey in Canada has shown that 
both health professionals and the postpartum women 
were aware of the importance of postpartum screening 
for type 2 diabetes [6]; nevertheless, other studies report 
low screening rates for postpartum screening in this high 
risk group of women [7, 8]. In screening trials and follow-
up studies of postpartum women it is well recognized 
that barriers and constraints for participation in screen-
ing are the main factors to eliminate if screening rates are 
to be increased [6, 9]. In a review of Nielsen et al., emo-
tional stress, time pressure, difficulties with adjustment 
to motherhood, and loss of requisition for screening were 
reported as barriers among the women for postpartum 
screening [9]. These barriers are patient perspectives; 
nevertheless, health professionals’ perspectives of bar-
riers are not yet investigated though relevant to target if 
screening rates should be increased: Reminder systems 
have shown to be a potential strategy also for improve-
ment of health professionals’ behaviour and to improve 
the health care process [10]. Pierce et  al. reported in 
their study among British primary and secondary care 
health professionals that 75 % had an installed reminder 
system to recall women to ensure postpartum screen-
ing [11]. Reminder systems; both electronic alerts for the 
health professional and letter or telephone reminders for 
the patient, are a known strategy for patient compliance 
improvement and have been evaluated for other out-
comes than diabetes [10, 12, 13].
In this systematic review, we aimed to study the effect 
of implemented reminder systems for postpartum type 
2 diabetes screening in the health care system where the 
reminders targeted either the health care professional 
and/or the postpartum women. The effect was measured 
as either the percentage of women who underwent an 
oral glucose tolerance test (OGTT) or other screenings 
tests for diabetes, or various secondary outcomes, such 
as response rates after the reminder, or attendance of any 
kind of follow-up visit.
Methods
Search strategy
We searched the Pubmed, Cinahl, Cochrane Review 
Database, and the Embase database for relevant studies. 
The search was performed from February to March 2014 
and was limited to include only English language litera-
ture published from 2004 to 2014. Before the literature 
search we settled for three criteria on which literature 
was included. Our main inclusion criterion was in rela-
tion to the study design: We preferred intervention stud-
ies; however, we allowed studies of observational design 
as well to be included if an effect of a reminder system 
could be measured or evaluated. Our second crite-
rion was in relation to the measured outcome: We were 
mainly interested in the rate of women undergoing a 
postpartum OGTT; however, we included other second-
ary outcomes; other postpartum glucose test, or rate of 
any kind of response from the postpartum women after 
the reminder was sent. Our third criterion was regarding 
the definition of a reminder: Reminders were defined as 
postal reminder, email reminders, or telephone calls/text 
messages for the patients. For health professionals we 
defined reminders as for the patients and additional the 
option of pop-up electronically implemented reminders/
alerts or simple reminders either in paper form posted 
on medical reports or implemented electronically in the 
patient registry system. No inclusion criteria regarding 
the content of the reminders, since we were interested in 
the effect seen after reminders were sent and not neces-
sarily received.
Clinical practice and guidelines for postpartum screen-
ing from the American Diabetes Association recom-
mend the first early screening should be around the first 
6–12 weeks postpartum, and every 1–3 years thereafter 
[4]. Thus, we were interested in both long term and early 
follow-up and compliance to screening. We defined the 
early term follow-up as the first postpartum follow-up 
visit, which is usually within the first 6 months after giv-
ing birth. Long term follow-up was defined as the fol-
lowing visits, usually 1 year after birth. According to this 
definition, we distinguish between the reminders related 
to the early follow-up visit, and the following reminders 
related to long-term follow-up no matter if the reminders 
sent after 12 months are the first reminders. In this way, 
women could miss the early follow-up but be reminded 
of the importance of follow-up and therefore attend a 
long-term follow-up visit.
According to the PRISMA guidelines the literature 
extraction was divided into four stages [14]: In stage 
one, the search strategy was initiated by the combina-
tion of three search words: “gestational diabetes*” AND 
“reminder*” AND “postpartum follow-up” OR “interven-
tion”. From that search we found 61 articles. From titles 
we excluded 29 articles, which were not relevant for the 
study question. After the database search the reference 
lists were further investigated in order to identify addi-
tional literature of interest. If only abstracts were avail-
able, the reference was disregarded. In the final stage, the 
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articles were chosen after a careful reading of abstract 
and method sections. Figure  1 shows the flow chart for 
the literature search for reviewing reminder system 
effect. Literature search was conducted by CJ and verified 
by an authorized librarian trained in scientific literature 
search.
Data extraction
The included studies shown in Table  1 targeted health-
care professionals, patients, or both. The studies could 
be either observational or experimental in design: Obser-
vational studies in the meaning of studies not directly 
intervening but rather studying the effect of introducing 
a reminder system. Intervention studies were character-
ised as interventions targeting a specific defined target 
group. We found three study protocols which we dis-
carded, though the studies would have been relevant if 
results were presented. Two articles were found relevant; 
however, only the abstract were available and published 
for poster presentations. We did not make contact to the 
authors. We ended up with the final six references that 
met the inclusion criteria and were included in the review.
Results
Search results
The included studies were published from 2009 to 2012 
and were conducted in Finland (1), Australia (1), United 
States (1), and Canada (3). Two studies focused on the 
long term postpartum screening: One study investigated 
the effect of reminders sent 15 months after delivery and 
every 12  months thereafter [15] where women accord-
ing to recommendation should have attended the first 
screening consultation and Vesco et  al. investigated the 
effect of reminders sent before and after 3 months after 
delivery [16]. However, all studies were conducted aiming 
at reminding of the first early postpartum glucose intol-
erance screening test. Ethical approval for this literature 
study was not required.
Population characteristics
Study populations differed between the studies. The 
effect of reminder systems were studied on patients only 
(N  =  3), and on both patients and health professionals 
(N  =  3). Health professionals included general practi-
tioners, endocrinologists, and medical residents [17, 18]. 
Records identified through PUBMED (16), CINAHL 
(12), Cochrane Review Database (2), Embase (31)
Abstracts  screened and 
included (N=24)
References in total based on tle 
(N=61) Arcles not relevant for study 
queson (N=29) and duplicates








Total number of arcles included:
6 intervenon studies including 
physicians/health care system as 
target group
Arcles including pregnant women, 
pre-pregnant women   as target 
group (N=16) 
Only abstracts available for posters 
(N=2)
Fig. 1 Literature search strategy










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Page 6 of 11Jeppesen et al. BMC Res Notes  (2015) 8:373 
Only one study reported age of the health profession-
als, and found 83.8 % were above 30 years of age [18]. In 
the three studies including patient reminders only, the 
patients were randomized according to a specific setting 
(clinical site being the intervention group) [19], patients 
belonging to a specific municipality [20], or patients were 
already included in a registry allocated to a clinical site 
(hospitals) or joint treatment organization [15, 16]. The 
studies reported the women’s age as mean or percentage 
under and over 30 or 35 years as cut-off points. Mean age 
(SD) ranged from 30.1 (±5.7) [20] to 34.9 (±5.2) [17]. In 
the papers reporting age ranges 72.8 % were over 30 years 
of age in Clark et al. [18] and in Vesco et al. [16] 30 and 
36.3  % in the pre-implementation of reminder system 
group and post-implementation of the reminder system 
group, respectively, were above 35 years of age. Only one 
study did not report the women’s age [15].
Reminder-systems
In the six studies included, the reminder-systems were 
either the main intervention [15, 18–20] or an integrated 
part of a larger intervention program [16]. In the study 
of Vesco et  al. the postal reminders for patients was a 
part of a larger process improvement program that also 
included revised nursing protocols for the GDM women, 
enhancing the electronic medical record system, and 
education of the clinical staff in addition to the postal 
patient reminders [16]. The results of Vesco et  al. were 
not divided into differentiated effects of the various initi-
atives and therefore the results are included in the patient 
reminder group. The health professionals’ reminders 
were based on system-based pop-up messages reminding 
the professional to recall women for postpartum check-
up. The patient reminders varied from telephone calls 
from nurses to the patient [16, 20] or letters or mailed 
reminders sent to the patient [18, 19].
Physician interventions
The primary sector and secondary sector are joint in the 
health care system by interaction around the patient; 
however, with different responsibilities and duties. In 
our definition, primary sector also include health care 
staff at elderly centres, pharmacies, and infant and neo-
natal health care providers for supporting the mother. 
General practitioners, as being the primary player in the 
primary sector, have first contact with citizens. Thus, 
the primary sector can in addition to being the first 
contact with patients also play a health promoting and 
disease preventive role towards the public. The second-
ary sector includes hospitals and specialised health care 
providers. The secondary sectors is responsible for the 
complex treatment of patients and the secondary sector 
can normally only be contacted by patients through a 
first contact to the primary sector. Going through the lit-
erature we therefor made a distinction among the health 
care professionals. Primary health providers are general 
practitioners since they act as a first point of consultation 
for the women with former gestational diabetes, however, 
secondary system play the dominating role treating the 
women during the pregnancy and preventing a worsen-
ing of the GDM state.
The occurrence of using reminder systems for recall-
ing postpartum women for glucose intolerance screen-
ing have been studied before [21]. Nonetheless, diverse 
results on the use of reminder systems exist: One study 
found that 8.2 % used an electronic alert or reminder to 
call women in for postpartum screening, but only 12.8 % 
of the 306 health professionals actually sent reminders to 
patients when it was time for postpartum screening [21]. 
Another study reported that 75 % of the secondary care 
specialists (obstetricians and gynaecologists) had an inte-
grated system in place to alert when postpartum women 
failed to attend their follow-up visit. Among these sec-
ondary care providers 73 % sent a notification to the gen-
eral practitioners (GP), proposing the GP to recall the 
women for follow-up [11].
Among the primary care GPs 39 % recalled women on 
an annual basis and 35  % advised the women to attend 
screening in the future. The perception of responsibil-
ity seems to be a factor affecting the recall of patients: 
45 % of the GPs thought it was the responsibility of the 
primary care sector to conduct early follow-up on pre-
vious GDM women; however, 26  % of the GPs thought 
there was no clear responsibility in any sector [11]. With 
the above results in mind, it is interesting to evaluate the 
effect reminders have on physicians and health profes-
sionals and the effect reminders have on screening rates 
of postpartum women.
We included two intervention studies with the focus 
on health professional alerts for recalling postpartum 
women: Clark et  al. made a 2*2 factorial randomized 
control design on patient and/or physician reminder 
interventions. The study included 256 eligible women 
and their 256 physicians. The randomized groups were 
designed as: physician reminders only; patient remind-
ers only; both physician and patient reminders; and no 
reminders (controls). The primary outcome of the study, 
as seen in Table  1, was the proportion of women who 
underwent an OGTT within 1 year after delivery and the 
reminder was sent approximately 3 months after delivery 
in order to conform with screening recommendations. 
Secondary outcome was measured as the performance 
of any kind of screening test. When only physicians were 
reminded, the postpartum women were more likely to 
undergo an OGTT [OR 8.4 (95 % CI 2.4; 28.5)] than if no 
reminders were sent (the control group). Interestingly, 
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the association with compliance to screening decreased 
if both the physician and the patient were reminded OR 
5.2 (95  %CI 1.4; 19.6) compared to controls. However, 
the results should be interpreted carefully since the study 
populations of both patients and physicians were small: 
after loss to follow-up 112 physicians remained for anal-
yses. The number of women in the three groups varied 
from 31 (physician reminders only) to 81 (both physician 
and patient reminders). Loss to follow-up was mainly 
due to movement of either patient or physician. This was 
taken into account in sensitivity analyses where the study 
assumed that patients lost to follow-up all underwent 
OGTT screening (analyses 1) or did not undergo OGTT 
screening (analyses 2). When assuming that none of the 
women lost to follow-up underwent OGTT the effect of 
the reminders to both patients and physicians and the 
interventions on physicians only remained significant, 
OR 3.9 (95 % CI 1.1; 13.9) and OR 4.8 (95 % CI 1.6; 14.9), 
respectively.
In Lega et  al. a retrospective observational study of a 
checklist procedure was evaluated. The study included 
314 postpartum women with previous GDM from an 
internal hospital record. From this study population 173 
of the women were enrolled with a checklist depicting to 
the health professionals whether the woman had attended 
her postpartum visit. The study was an evaluation of the 
effect of implementing this checklist procedure in the 
register. Therefore no direct intervention took place; 
however, having a checklist registered was shown to be 
associated with completed OGTT between 6 weeks and 
6 months postpartum by OR 2.99 (95 % CI 1.84; 4.85). As 
for the study of Clark et al., this study also had second-
ary outcomes measured as the rate of women attending 
a postpartum visit, not necessary completing an OGTT. 
The registration of a checklist for the patient was posi-
tively associated with attending a postpartum visit within 
the same time frame as for OGTT: OR 3.71 (95 % CI 2.26; 
6.11). Since no direct intervention took place, a major 
strength of the study was no loss to follow-up and the 
directly effect on the registration of the patients the effect 
of a checklist targeting the attention of the health profes-
sional. Nevertheless, the study did not discuss differences 
in the allocation of a checklist and if the allocation could 
confound the results in any way. Both the study of Lega 
et al. and Clark et al. had the outcome of increasing the 
first screening after birth (early term screening) meaning 
undergoing an OGTT within 6 months after delivery.
Based on these two studies it seems plausible that 
reminders for health professionals can increase the post-
partum OGTT screening among women with previous 
GDM. However, this conclusion is based on two stud-
ies only, where one study had a large loss to follow-up 
and the large differences in the number of intervention 
groups. Furthermore, the conclusion can only be drawn 
on the first early screening after delivery and not on a 
long term basis. Furthermore, interestingly it seems that 
reminding both patient and physician does not result in 
increased screening rates compared to reminding either 
patients or physicians.
Patient interventions
The most recent study on patients’ perception of health 
professionals’ responsibility for postpartum screening 
revealed that primary care providers, such as general 
practitioners, were responsible for the recall of women 
for postpartum OGTT. Out of 136 postpartum patients 
76 % thought it was the GP, whereas 8.8 % thought it was 
the responsibility of the obstetrician only, and 11.8  % 
thought it was the health professional treating them for 
gestational diabetes [6]. This confusion of which health 
professional to turn to for postpartum diabetes screening 
could potentially influence screening rates among post-
partum patients in some countries. Furthermore, a quali-
tative study conducted in the Johns Hopkins Bayview 
Medical Center’s obstetric clinical practice revealed that 
receiving care from multiple providers and lack of con-
tinuity of care were barriers for women’s participation in 
postpartum screening [22].
Reminder-systems for patients could provide this con-
tinuity of care but also a continuity of the awareness 
of the risk for development of diabetes. In the study of 
Shea et al. two clinical sites were allocated to have imple-
mented reminder systems contacting the postpartum 
patients by telephone or letter [19]. Despite that the 
patient groups had a large variation in number of patients 
(control site: 117, site A: 90, site B: 55) 28 % of patients, 
when adding site A and B together, returned for a post-
partum visit and completed an OGTT test compared to 
13.75  % (p  =  0.01) from the control site. In this inter-
vention site A and B differed: In site A only laboratory 
requisitions and reminder letters were sent. In site B 
reminder letters were sent, and an additional telephone 
call was made. This difference in reminder approach 
resulted in a stronger association of site B with comple-
tion of OGTT: OR 3.10 (95  % CI 1.35; 7.14) compared 
to the non-reminder control site whereas site A had an 
OR 1.57 (95 % CI 0.66; 3.70) compared to the control site. 
When the outcome was set as completion of any kind of 
screening test including HbA1c, random glucose test, or 
fasting glucose test the difference in association between 
site A and B attenuated: OR: 1.09 (95 % CI 0.56; 2.13) and 
OR 1.33 (95 % CI 0.65; 2.71) for site A vs control site and 
site B vs. control site, respectively [19]. In Korpi-Hyövälti 
et  al. a similar reminder approach was implemented: 
High risk-of-GDM women were called by health care 
nurses encouraging the women to complete a visit for 
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an OGTT test. Of the women who completed an OGTT 
83.2  % had received a phone call compared to 49.1  % 
completing OGTT in the group of women not receiving 
phone reminders [20].
The potential of personal approach reminders, such 
as phone call, is significant and a personal approach can 
have a large effect whereas letters and emails that can be 
perceived less personal and committing to the patients 
still have an effect on screening rates; nonetheless, they 
are less effective than phone calls. This is in consistence 
with qualitative research findings; a personal approach 
from medical staff to the patient enhances the commit-
ment of the patient [22].
The number of reminders is another factor influencing 
screening rates. In Chittleborough et al. 817 postpartum 
women registered in the Gestational Diabetes Mellitus 
Recall Register allocated at three local hospitals received 
up to 6 reminders over a period of 6  years. The main 
outcome was the return of an update form and second, 
the information of completion of an OGTT the previous 
12 months. The proportion of women who returned the 
update form declined over time; however, the percent-
age of women who reported to have an OGTT com-
pleted remained high: 56.3 % of 429 women after the first 
reminder letter and 66.7  % of 26 women after the sixth 
reminder letter. In Vesco et  al. it was reported that an 
implementation of staff education combined with patient 
reminders that included telephone call, email or letter, 
and in-person reminder in 7 clinics handling postpar-
tum follow-up visits increased screening rates signifi-
cantly. After the implementation, cox regression analysis 
revealed a HR 1.37 (95  % CI 1.10; 1.70) for completion 
of screening. Screening was defined as completed OGTT, 
or measured fasting glucose. The number of reminders 
influenced the completion rate: after the first reminder 
80 % of the women completed a glucose test (either fast-
ing or OGTT). According to the authors 41  % of the 
remaining completed after second reminder and after the 
third reminder 28 % of the women completed the ordered 
glucose test [16].
Staff education and awareness in combination 
with reminder systems
In the study of Vesco et al. the reminder system was com-
bined with implementation of an educational interven-
tion among the health staff [16]. The study found that the 
implementation of staff education has obviously influ-
enced awareness of reminding women to undergo screen-
ing. The largest effect on the amount of reminders send 
was seen on a long-term aspect where the proportion 
of any kind of the three mentioned reminders increased 
from 27 to 59 % (p < 0.0001). This is not surprising since 
other studies have found that integrated study protocols 
that help the health professional will improve keep-
ing focus on and prioritize high risk patients: Ko et  al. 
reported that more than half of their study population 
of obstetricians and gynaecologist (N = 306) reported to 
have clinical guidelines addressing postpartum screening 
integrated in their practice. Clinical guidelines were more 
widespread in clinics of frequent screeners. If the obste-
tricians and gynaecologists reported to screen the women 
“always” or “most of the time” the authors’ defined the 
health professional to be “frequent screener”. Likewise, 
health professionals who reported “sometimes”, “rarely” 
or “never” to conduct screening were characterised as 
“infrequent screeners” [21]. Furthermore, the obstetri-
cians and gynaecologists identified as frequent postpar-
tum screeners were more likely to consider screening a 
priority in their practice (25.5  % for frequent screeners 
vs. 13.3 % for non-frequent screeners, p < 0.001) [21]. In 
line with this, Hunsberger et  al. conducted a mail sur-
vey among family medicine physicians and specialized 
physicians in obstetric or gynaecology. They found that 
postpartum screening rates depended on whether it was 
a priority of the physician or clinic (OR 4.39, 95  % CI 
1.69–7.94) and mostly if the physician thought screening 
was the norm among this special group of patients [OR 
3.66, 95 % CI (1.65–11.69)]. However, the study had a low 
response rate of only 42 % in total (N =  285) and 58 % 
(N =  166) of these were family physicians compared to 
42 % (N = 119) obstetricians or gynaecologists [23].
Discussion
In this systematic review we studied the effect of remind-
ers for health care professionals and/or postpartum 
women with previous GDM or reminder systems inte-
grated in secondary or primary care. For the patient 
reminders it seems that personal reminders have a bet-
ter effect on the screening rates and Chittleborough et al. 
showed that even though the response rate from each 
reminder sent declined—the proportion of women com-
pleting OGTT over time remained high. Furthermore, 
patient reminder systems can with benefit be combined 
with educational interventions among the health profes-
sionals to increase awareness of the importance of using 
the reminder system.
A recent review on barriers for gestational diabe-
tes screening and barriers for the subsequent postpar-
tum screening revealed that time and the new role as a 
mother were the two main barriers among patients [9]. 
However, few studies have so far been interested in the 
barriers that may exist among health professional con-
ducting screening test among this high risk for diabetes 
patient group. Two studies only had the main aim of their 
questionnaire surveys to study barriers among health 
professionals: Stuebe et  al. identified various barriers 
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among the participating physicians: poor communica-
tion between primary care physicians and secondary care 
specialists, and poor documentation in the electronic 
record of gestational diabetes (filed for 45.8 % of women 
only), even though this was recommended [24]. In Kee-
ley et al., the barriers for not screening patients was that 
the physician did not have consultations with the patient. 
This was reported by 37 % of the 63 physicians that did 
not screen their patients. The second most common bar-
rier for not screening was reported by 33 % and was due 
to non-arrangement of the test, even though there has 
been a consultation regarding other health problems. 
Lack of awareness regarding the screening issue between 
health professionals and between health professional and 
patient could be solved by integrated reminder systems 
alerting the professionals either to contact other pro-
fessionals or to call in women for screening. Integrated 
reminder systems could automatically send out remind-
ers for patients as well.
The use of reminder systems is not a new intervention. 
Randomized controlled trials have evaluated the effect 
of reminder alerts for physicians in order to increase 
screening rates for colorectal cancer [25], mammography 
[26], and breast- and cervical cancer [27]. These studies 
provide evidence for the improvement that implemented 
reminder systems can give for these specific diseases. 
However, it does not mean it will be effective for increas-
ing postpartum screening rates but definitely leave 
potentials for trials to replicate interventions in order 
to find suitable reminder systems for health profession-
als handling postpartum testing of women. One study 
found significantly higher screenings rates for deficien-
cies, hypertension and diabetes among elderly patients in 
an ordinary primary care setting in Stockholm, Sweden 
where a reminder system had been implemented among 
GPs. The study found significantly higher rates of sys-
tolic blood pressure, and cobalamin deficiency, whereas 
the rates of diabetes and anaemia were non-significantly 
increased among elderly patients of the GPS in the inter-
vention group. The authors concluded that implemen-
tation of this reminder system in a primary care setting 
[28] could have similar benefits in a secondary sector set-
ting. It was in an updated Cochrane Review concluded 
that mobile phone text messaging reminders increased 
attendance at healthcare appointments and this was 
compared to no reminders, or postal reminders [12].
One could speculate on the effectiveness of the remind-
ers. The effect of reminders and implementations of 
reminder systems for either health professionals or 
patients could be improved by increasing the amount of 
information e.g. by patient specific campaigns, on the 
importance of postpartum screening and the awareness 
of the risk of developing type 2 diabetes.
Strengths and limitations
We have several limitations in our study. The most obvi-
ous is the lack of controlled randomised intervention 
studies. A similar systematic review investigating remind-
ers for women with previous GDM included randomised 
controlled trials only [29]. This systematic review ended 
up with only one study in their analyses. In our opin-
ion, other studies not necessary of interventional design 
can provide valuable information as well. We therefore 
broadened our search to include non-randomised studies 
and observational studies. However, with the lack of ran-
domised controlled trials we are not able to study nega-
tive results of reminder systems or studies showing no 
effect. Another large limitation is the lack of long-term 
follow-up studies: four out of six studies focused on early 
term follow-up within the first year after giving birth. 
This leaves us with scarce results and unable to make 
solid conclusions for a long-term effect of reminders for 
postpartum screening. Finally, we were able to find one 
study focusing on primary care health setting, whereas 
the other five focused on secondary health care setting. 
A large diversity between countries variations exist when 
it comes to postpartum follow-up visits. In Denmark, 
women are encouraged to attend their postpartum diabe-
tes screening at their general practitioner.
Nevertheless, a strength of our study is the variation in 
type of reminders used. Effect of letters, telephone calls 
or emails for patients, and reminders attached to medi-
cal files or register-based reminders to health profes-
sionals were included in the studies. Despite the type of 
reminder—all reminders had an effect. This is important 
seen from a general point of view: The use of reminders 
and reminder systems has one aim: to increase awareness 
of the importance of attending the recommended post-
partum diabetes screening. From a patient point of view 
awareness on the risk of developing diabetes has to be 
maintained. From the health professional’s point of view 
reminder systems help to keep track on patients and rates 
of follow-up. Therefore, we see it as an important find-
ing, that all the articles showed an effect despite type of 
reminder.
Conclusions
The included studies have shown that both reminder sys-
tems to patients and to health professionals are successful 
in increasing postpartum screening rates. Nevertheless, 
screening rates and effectiveness have to be differenti-
ated in early and long term effects postpartum. Evidence 
is scarce for long term effects past the first follow-up 
visit or with visits placed after the first year postpartum. 
The number of reminders sent to patients and the kind 
of reminder also influence the effectiveness in a way that 
personal confrontation reminders such as telephone 
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calls are more effective than letters. For the number of 
reminders evidence is lacking, however, it seems that 
with numerous reminders more women will undergo a 
follow-up visit over time; nevertheless, some women will 
not attend or will refuse to attend.
Due to lack of evidence, future research could focus 
on longer term compliance to screening among women 
with previous GDM to see the effect of reminder systems 
ideally both for health professionals and for patients. 
One could speculate, whether postpartum health com-
munication could be linked to health examinations of 
the child when the woman is at the general practitioner. 
In this way, pop-up reminders linking child examination 
and postpartum examination would benefit the aware-
ness among the professionals and patients, and by that 
mean, solve one of the main barriers identified among 
health professionals [9]: lack of awareness and contact to 
the patient, and inadequate knowledge exchange among 
professionals.
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